FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3456111000001106: Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17322101000001111 Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60508801000001114 Conjugated oestrogens 625microgram / Medroxyprogesterone 10mg tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Is a Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has active ingredient Conjugated estrogen false Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has active ingredient Medroxyprogesterone acetate false Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has active ingredient Medroxyprogesterone false Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has excipient Lactose false Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has specific active ingredient Conjugated estrogen true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has specific active ingredient Medroxyprogesterone acetate true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) 42 tablet Is pack of False Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier
Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) 42 tablet Has AMP True Medroxyprogesterone 10mg / Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start